Although there has been substantial improvement in atherosclerotic cardiovascular disease (ASCVD) outcomes in recent decades, ASCVD remains the leading cause of morbidity and …
Summary of the Clinical Problem Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death in the United States. Most individuals who develop ASCVD have …
RH Eckel, JM Jakicic, JD Ard, JM de Jesus, NH Miller… - Circulation, 2014 - Am Heart Assoc
The goals of the American College of Cardiology (ACC) and the American Heart Association (AHA) are to prevent cardiovascular diseases (CVDs); improve the management of people …
I Fegers-Wustrow, E Gianos, M Halle, E Yang - Journal of the American …, 2022 - jacc.org
This review compares the primary prevention recommendations of the recent 2021 European Society of Cardiology (ESC) and 2019 American College of Cardiology …
European Journal of Preventive Cardiology, 2012 - journals.sagepub.com
Atherosclerotic cardiovascular disease (CVD) is a chronic disorder developing insidiously throughout life and usually progressing to an advanced stage by the time symptoms occur. It …
The content of these European Society of Cardiology (ESC) Guidelines has been published for personal and educational use only. No commercial use is authorized. No part of the ESC …
I Graham, D Atar, K Borch-Johnsen… - European heart …, 2007 - academic.oup.com
†European guidelines on cardiovascular disease prevention in clinical practice: executive summary | European Heart Journal | Oxford Academic Skip to Main Content Advertisement …
(ACCF) guidelines on secondary prevention, 1 important evidence from clinical trials has emerged that further supports and broadens the merits of intensive risk-reduction therapies …
BA Franklin, M Cushman - Circulation, 2011 - Am Heart Assoc
Multifactorial risk factor modification and control, espe-cially interventions designed to reduce total cholesterol, systolic blood pressure, smoking prevalence, overweight/obesity …